Table 3.
Interaction between covariates in the final population pharmacokinetic model and the influence of covariate combinations on CL/F.
10 | 30 | 50 | 70 | 90 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
AST (IU lā1) CYP3A4 (yes/no) | no | yes | no | yes | no | yes | no | yes | no | yes |
Age (y) | CL/F (l hā1) | |||||||||
20 | 69 | 60 | 61 | 53 | 53 | 46 | 45 | 39 | 37 | 32 |
40 | 65 | 56 | 57 | 49 | 50 | 43 | 42 | 36 | 34 | 30 |
60 | 60 | 52 | 53 | 46 | 46 | 40 | 39 | 34 | 32 | 28 |
80 | 56 | 48 | 49 | 42 | 43 | 37 | 36 | 31 | 30 | 26 |
CL/F=apparent clearance; AST=aspartate transaminase.